Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

The Pashmina Store Announces Top 7 Cashmere Holiday Gift Ideas for 2020


This year’s top cashmere gifts are focused mainly on the classics – with a few surprises to keep things interesting

The Pashmina Store, one of the largest online retailers of 100% pure, grade A cashmere, today announced its top 7 cashmere gift ideas for the 2020 holiday season:

1) Pure Pashmina Wraps

2) Men’s Cashmere Scarves

3) Animal Prints

4) Pure Cashmere Baby Blanket Ladybug Design

5) Elegant Water Style Pashmina Silk Stoles

6) Pashmina and Silk Basket Weave Stole

7) Knit Cashmere Bed Socks

“This year’s top cashmere gifts are focused mainly on the classics – with a few surprises to keep things interesting,” said Blair Rhodes of The Pashmina Store. “For customers who prefer gift certificates, our new partnership with PayPal is exciting because it makes it so easy to give, receive and use our gift certificates.”

Customers can order conveniently online at http://www.thepashminastore.com. PayPal Gifts may be obtained by searching for ‘The Pashmina Store’ at http://www.PayPal.com/us/gifts.

About The Pashmina Store

Since 2001, The Pashmina Store has been proud to offer the finest quality pure pashmina and pashmina/silk blend shawls, wraps, scarves, cashmere blankets and other fashion accessories. Customers enjoy the entire experience with quality products at exceptional values, free standard shipping in the U.S from Texas, and a satisfaction guarantee.

Share article on social media or email:

Upgraid Joins Forces with Naturex to Deliver Organic Ingredients Backed by Clinical Science


Upgraid, the first ever wellness company with a science-based approach, has announced a collaboration with Naturex, part of Givaudan, to expand its product portfolio.

Through the collaboration, Naturex will provide Upgraid with state-of-the-art clinical science that backs the benefits of natural formulations increasingly in demand in the market today. This will allow Upgraid greater focus in delivering better, healthier, organic ingredients to consumers.

“All organics are not created equal,” said Helene Rutledge, co-founder of Upgraid. ”Naturex is known as a best in class provider of the finest organic, sustainable, ethically sourced raw ingredients available. Their worldwide network of agronomists works closely with local partners to facilitate responsible practices in the supply chain, biodiversity, and local entrepreneurship. Our collaboration will provide better solutions to a society rapidly moving towards proactive, plant-based preventative health and wellness lifestyles.”

The collaboration of the two companies began with the launch of Upgraid’s first product, Perform: Daily Inflammation (™). Perform: Daily Inflammation (™) is backed by rigorous clinical data and demonstrated to help reduce soreness and recovery time, when taken daily, proactively. It is a standardized, proprietary blend of the following organic ingredients found in nature and formulated by scientists to work better together.

Naturex’s TurmiPure Gold®, the most bioavailable organic turmeric extract, which has been associated with helping to support healthy joint function Organic ashwagandha, which has been shown to help consumers manage stress by maintaining healthy cortisol levels Organic tart cherry fruit and organic ginger root, which have shown effects in supporting the immune system and reducing muscle soreness.

The two companies will continue using the collaboration as a growth catalyst through future product launches. In exchange for playing a significant role in Upgraid’s product expansion, Naturex will gain exclusive access to Upgraid’s consumer-facing market innovation, psychographics, and purchasing analytics.

“We are excited about the collaboration and have been impressed by Upgraid’s rigorous review of the science behind the ingredients they use,” stated Emilie Fromentin, Head of Explore Health, Wellness and Nutrition at Givaudan Taste & Wellbeing. “We look forward to providing our expertise, high quality ingredients and state-of-the-art science and formulation knowledge to help contribute to beneficial outcomes for customers.”

With a mission to reduce the amount of daily artificial ingredients that society takes, Upgraid aims to do just that – provide beneficial outcomes for customers by delivering clinically tested and science-backed products with zero chemicals, zero compromise, and zero false promises backed by 100% transparency and organic ingredients.

“We came together to take a rigorous, scientific approach to fully organic products,” said Justin Kamine, co-founder of Upgraid. “Reverting society and human health to the way we started, by using diet as a form of preventative healthcare. Being proactive and preventative is much needed. Unfortunately, we have become accustomed to too many quick fixes rather than addressing the underlying problems.”

Neither Perform: Daily Inflammation™ nor TurmiPure Gold® are intended to diagnose, treat, mitigate, prevent or cure any disease or medical condition.

###

About Upgraid

Upgraid is an organic wellness company that drives healthy aging by developing and leveraging the latest technology and market innovation. Founded by Helene Rutledge, a chemical engineer and former big pharma C-suite executive, and Justin Kamine, a Forbes 30U30 for food and impact entrepreneur. Upgraid supplements help consumers to get a little better every day.

For further information, visit https://www.upgraid.me/.

About Naturex, part of Givaudan

Naturex sources, manufactures and markets natural specialty ingredients for the food and health industries. Naturex’s portfolio includes natural preservation ingredients, specialty fruits and vegetables, phytoactives, and numerous other plant-based natural ingredients, designed to help its customers switch to natural ingredients and create healthy, authentic, and effective products. The success of the company is based on a strong commitment to sustainability, continuous innovation, and the talent of its people. Naturex is part of Givaudan, the global leader in the creation of flavors and fragrances.

Learn more about Naturex at http://www.naturex.com

About Givaudan Taste & Wellbeing

Powered by innovation and creativity, Givaudan Taste & Wellbeing aims to shape the future of food by becoming the co-creation partner of choice to its customers. Built on its global leadership position in flavours and taste, the Company goes beyond to create food experiences that do good and feel good, for body, mind and planet. With an expanded portfolio of products across flavours, taste, functional and nutritional solutions and a deep knowledge of the food ecosystem, Givaudan’s passion is to collaborate with customers and partners to develop game-changing innovations in food and beverage. Let’s imagine together the future of food.

Learn more at http://www.givaudan.com/taste-wellbeing

MEDIA CONTACTS

Sparkpr for Upgraid

upgraid@sparkpr.com

Stephen Collins, Head of NOAM Communications, Givaudan Taste & Wellbeing

Stephen.collins@givaudan.com

Share article on social media or email:

Responsum Health and IgA Nephropathy Foundation Announce New Partnership


“We are excited to partner with Responsum Health. This opportunity will bring valuable information to the patients we serve much faster than we possibly could,” said Founder and Executive Director of the IgAN Foundation Bonnie Schneider.

Today, Responsum Health (Responsum), an innovative developer of personalized patient apps and chronic disease knowledge communities, announces a new partnership with the IgA Nephropathy Foundation, a patient-focused non-profit organization for Immunoglobulin A nephropathy (IgAN) dedicated to both the funding of research for IgAN and patient advocacy.

Through this joint effort between Responsum Health and the IgAN Foundation, the goal is to continually improve available education and support for those who are impacted by IgAN. Through the Responsum for CKD app, professionally vetted information on IgAN will be distributed to the chronic kidney disease community, as well as syndicated to those with an IgAN Foundation membership.

IgAN is a form of chronic kidney disease in which an antibody blood protein, Immunoglobulin A, accumulates in the kidneys and causes damage. It is considered a rare disease by the National Organization of Rare Disorders, which means it affects less than 200,000 people in the U.S.—though it often goes undiagnosed.

In raising awareness and education on IgAN and empowering patients through community, knowledge, and resources, Responsum Health supports the IgAN Foundation’s mission to encourage additional research on IgAN. As many as half of those with IgAN will develop end-stage kidney disease, which limits treatment options to dialysis and/or transplant. For this reason, increased support for IgAN research is necessary to better understand the disease, lead to improved diagnosis, and an eventual cure.

“Partnering on this initiative with the IgAN Foundation represents an important step towards the fulfillment of our vision to leverage Responsum’s uniquely impactful digital platforms—in collaboration with the leading subject matter experts in chronic disease—to expand and improve patients’ access to trustworthy information,” stated Founder and CEO of Responsum Health Andrew Rosenberg. “We are excited and honored to be working with such a highly respected organization.”

“We are excited to partner with Responsum Health. This opportunity will bring valuable information to the patients we serve much faster than we possibly could,” said Founder and Executive Director of the IgAN Foundation Bonnie Schneider. “There is so much happening in our IgAN space that time is of the essence to educate our patients. This will allow them to make empowered decisions about their disease journey.”

About Responsum Health

Responsum Health’s mission is to build and support online knowledge communities for chronic disease patients. The company offers a free, revolutionary patient engagement platform that monitors, searches, and curates the internet to generate a personalized Newsfeed of article summaries, which are vetted by Responsum’s patient group partners. Each comprehensive platform enables patients to comment on and rate articles, as well as share them with their professional care team and loved ones. Responsum also helps patients to better organize their health information, find local patient support groups and services, and support one another through a moderated, disease-specific social wall.

About IgA Nephropathy Foundation

The IgA Nephropathy Foundation’s mission is to be a patient-centric organization focused on finding a cure for Immunoglobulin A nephropathy (IgAN). Using the power of the patient community, the IgAN Foundation is focused on funding research, using patient advocacy to empower IgAN patients, and building a network of support.

Share article on social media or email:

CE Health Interactive Launches Unprecedented OnDemand Medical Education Video as a Resource for Medical Professionals Serving Black Patients During COVID-19


CE Health Interactive Logo

“Although co-morbidities are a factor, we know there are gaps in knowledge, education and practice when it comes to managing the needs of the African American community during this time,” says Kenneth R Alleyne, M.D., orthopedic surgeon and chair of Connecticut Health Foundation Board.

COVID-19 has revealed several things about the U.S. health and medical industry. Among them is the lack of response and empathy for people of color, specifically African Americans. Already at higher risks due to pre-existing conditions, the Black community requires a unique and informed response from medical professionals to address the specific needs of those who contract Coronavirus. Announcing today, CE Health Interactive (CEHI), a leading provider of cutting-edge medical educational programs launches a certified educational video to support medical professionals servicing the African American community during the COVID-19 pandemic. The educational video is accredited by the Postgraduate Institute for Medicine(PIM).

According to a National Urban League study, based on data from John Hopkins University, Black Americans are twice as likely to die from COVID-19 related illness than white Americans. With an infection rate of 62 for every 10,000 people, Black Americans are three times as likely to be infected with the virus than their white counterparts.

“Although co-morbidities are a factor,” says Kenneth R Alleyne, M.D., orthopedic surgeon and chair of Connecticut Health Foundation Board. “We know that there are gaps in knowledge, education and practice when it comes to managing the needs of the African American community during this time as it relates to the pandemic. Current treatment options focus on addressing symptomatology. We believe a physician-led program may be beneficial for capturing a larger audience of HCPs. The provision of newer methods for implementing diagnostic and treatment options into the clinicians armamentarium for addressing the symptom and disease progression of COVID-19, as well as the morbidity and mortality rates of Black Americans, are tantamount to achieving improved outcomes.”

“We will be able to use our award-winning MedXchange Live Studio platform to create and feature impactful faculty didactic presentations,” said Calvin L. Butts Jr., board member, CE Health Interactive. “In addition, we will use our platform to moderate panel discussions that will allow for engaging conversation between clinicians and clinical experts.”

In addition to Alleyne, the panel discussion will be led by Reginald Eadie, president and CEO, Trinity Health of New England, and Cheryl R. Whitaker, MD, MPH, FACP, president, Institute of Medicine Chicago and CEO, NextLevel Health.

Topics will include:

  • Meeting the medical needs of African American patients with COVID-19
  • Data limitations on COVID-19 and African American patients
  • Meeting the social determinants of Health needs of At-Risk African American Patients during the Pandemic

Watch the discussion here.

###

About CE Health Interactive

CE Health Interactive (CEHI) designs and executes innovative, compelling and interactive continuing medical education (CME) programs. In the past 15 years, our engaging programs have educated 800k clinicians to improve patient care in cardiology, rheumatology, diabetes, psychology, oncology and other areas of medicine. Our proprietary and award-winning MedExchange Live platform fosters communications among practitioners, caregivers and patients. We also identify proven solutions and technologies from other industries and use them to create novel education programs. CE Health Interactive is minority-owned and operated. For more information, visit http://www.cehealthinteractive.com and contact us at Info@cehealthinteractive.com.

About Postgraduate Institute for Medicine (PIM)

In support of improving patient care, PIM is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. PIM is one of a very select group of jointly accredited providers that has been awarded the highest level of a 6-year term, placing PIM among the top echelon of CME/CE providers that have demonstrated the highest levels of educational acumen in providing healthcare professionals with relevant, effective, practice-based continuing education that supports US health care quality improvement.

Share article on social media or email:

Claire’s Place Foundation Receives Grant From Vertex Pharmaceuticals for Work Proudly Program


“The program is so needed and timely and we are honored that Vertex, a global biotechnology company, as well as independent organizations and individuals all recognize this urgent need in our community,” said Claire’s Place Foundation Executive Director Melissa Yeager.

Claire’s Place Foundation, a non-profit organization providing support to children and families affected by cystic fibrosis (CF), is proud to announce that Vertex Pharmaceuticals Incorporated has awarded the foundation with a grant of $50,000 to support their Work Proudly Program. The grant is provided by the Vertex Circle of Care program, a competitive grant opportunity that funds innovative patient-centric programs for the CF community.

The Claire’s Place Foundation Work Proudly Program provides job training and equipment needed for work-from-home employment to adults with CF and caregivers. The program helps people like Amanada whose son Jonathan has CF. The strain on her professional life and her family’s finances has been far greater than she anticipated. Jonathan is now 13 years old, and Amanda has lost count of the number of times she has lost a job because she missed work while Jonathan was hospitalized. “I can no longer keep this depressing cycle of loss going,” Amanda says. “I want a way to sustain myself and my family during trying times.”

In 2018, only 39% of adults with CF had a college degree, and just 52% were employed. To help the CF community, the Work Proudly Program identifies potential careers, covers the cost of certificate job training and provides the technology needed for remote work. Through the program, CF patients and caregivers will see reduced unemployment and increased earning potential and self-esteem.

Since the program’s launch in August 2020, the Work Proudly Program has attracted numerous partners. The generous partners are donating needed computers, tech support, career coaching and funds to help the participants kick-off their career from the safety of their home. Partners include:

human-I-T: Donated laptops and one year of tech support and internet service

Former Claire’s Place Board Member Dave Gersholowitz: Donated computers for the first 15 Work Proudly Program participants

Certified Professional Career Coach Ashlee Anderson – Donating her career coaching services to help program participants identify a career interest and a path to employment

Founder of Transcribeanywhere.com Janet Shaughnessy: Providing a discounted price for all of her transcription courses to program participants

Ashworth College: Providing a registration liaison for program participants making registration and third party payments seamless

Mary and Joseph Family Fund: Donated $5000 in honor of the late Donna Frantom

“We are extremely grateful for the influx of support for our new Work Proudly Program,” said Claire’s Place Foundation Executive Director Melissa Yeager. “The program is so needed and timely and we are honored that Vertex, a global biotechnology company, as well as independent organizations and individuals all recognize this urgent need in our community. My daughter Claire personally experienced how difficult it was as a young adult with CF to find flexible employment that would provide her with a sustainable income. We created the Work Proudly Program to help CF patients and caregivers live proudly and that includes having a fulfilling career. We are thankful not only for our partners’ show of confidence and support of our program, but also for their commitment to helping people living with this disease.”

Claire’s Place Foundation will pilot the Work Proudly Program through June 2021, participants will be recruited through a social worker referral found on our website. To help support the Claire’s Place Foundation Work Proudly Program please visit here to donate.

About Claire’s Place Foundation, Inc.

Claire’s Place Foundation, Inc. is a 501(c)(3) non-profit organization providing support to children and families affected by cystic fibrosis (CF). Claire’s Place Foundation is named in honor of Claire Wineland who lived with CF her entire life and passed away at the age of 21. Claire was an activist, author, TEDx Speaker, social media star and received numerous awards. Claire’s foundation was a way for her to assure that others living with CF enjoyed the same hope, strength and joy that she enjoyed. Recipient of Los Angeles Business Journal’s “Small Nonprofit of the Year,” the foundation provides grants to families affected by CF, offering both emotional and financial support. Today, Claire’s Place Foundation continues to carry on Claire’s legacy. For more information and make a donation, please visit http://www.clairesplacefoundation.org.

Share article on social media or email:

Catalent to Invest $10 Million to Expand High Potency Containment Capabilities For Micronization


Catalent offers multiple tools and technologies to drug innovators to improve the characteristics and efficacy of new molecules

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it is investing $10 million in isolator capabilities at its sites in Malvern, Pennsylvania and Dartford, U.K., to expand its micronization capabilities for highly potent drug compounds.

The investment will allow flexible jet milling operations to be carried out at both sites under containment to a working occupational exposure limit (OEL) of 0.05 micrograms per cubic meter, enabling micronization of potent and highly potent compounds, at less than 10 and less than 1 microgram per cubic meter respectively. Additionally, the capability to operate under an inert nitrogen environment offers enhanced manufacturing safety, eliminates the risk of dust explosion for compounds with low minimum ignition energy (MIE) values, and enables the processing of humidity, light and oxygen-sensitive materials. Work is underway at both facilities, with installation and validation activities likely to be completed by mid-2021.

At Dartford, the isolator will encompass a K-Tron gravimetric feeder with KT35 hopper and feed screws, suitable for 8-inch and 12-inch jet mills. The DEC Group designed system will be fully automated and allow product and waste to be collected within a safe, controlled environment. At the Malvern facility, the nine-chamber isolator will be housed within a new extension at the site, and will be one of the biggest isolators installed in the United States. The multi-chamber design, undertaken by FPS Architects & Engineers Limited, offers superior ergonomics and is optimized to significantly reduce cleaning and maintenance time.

“Catalent offers multiple tools and technologies to drug innovators to improve the characteristics and efficacy of new molecules, and micronization is an important engineering step for many materials to help improve the solubility of oral drugs and optimize inhaled therapies,” commented James Walter, Vice President Operations, Oral and Specialty Delivery at Catalent. “This investment allows us to ensure that access to this technology is not limited, as we see the development of highly potent molecules becoming more prevalent in the small molecule R&D pipeline against a number of disease targets.”

The Dartford and Malvern sites offer world-leading expertise and experience in particle size reduction capabilities including micronization, jet milling, mechanical milling, cryogenic milling and associated analytical services, and work alongside Catalent’s network of commercial-scale facilities. The company recently announced the launch of its OneXpress™ solution to integrate and accelerate a program’s transition from early-phase development to commercial-ready manufacturing by leveraging its phase-appropriate scale, technologies, extensive oral dose form network and expertise to reduce risk, complexity and cost between phases.

About Catalent

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs approximately 14,000 people, including around 2,400 scientists and technicians, at more than 45 facilities, and in fiscal year 2020 generated over $3 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Share article on social media or email:

Hydra Studios Raises $3.8M to Set a New Industry Standard for Health and Wellness Spaces


Hydra Studios, a network of elevated wellness studios for the modern workforce and the first-of-its-kind self-care destination with COVID-19 considerations built into its DNA, today announced a $3.8M seed capital round from investors Slow Ventures, Company Ventures, Courtside Ventures, CityRock Venture Partners, Hatzimemos/Libby, and Fifth Wall. The funding supports Hydra Studios’ first flagship studio, future network expansion, and key hires.

Founded by former Goldman Sachs colleagues Marie Kloor and Dan Nielsen, the concept for Hydra Studios was inspired by Kloor’s use of the firm’s upscale gym locker room as a “second home base, a hub between my work, social, and fitness lives.” Recognizing that access to these types of amenities were generally limited to employees of large companies, she saw an opportunity to create a new platform for a broader client base.

Just as construction was set to begin, the pandemic hit.

“We immediately needed to rethink and redesign our studio and its operations, pivoting from creating a communal experience to a more private one,” said Hydra Studios co-founder Marie Kloor, who serves as the company’s CEO.

The flagship now features private suites outfitted with HEPA air filters where clients can exercise, meditate, or simply recharge; the space itself features a newly upgraded ventilation system and antimicrobial surfaces.

Said Kloor, “We believe this is the ideal solution for personal fitness, wellness, and rejuvenation.”

“Moving forward, we hope to become an integral part of companies’ back-to-office plans,” said Dan Nielsen, co-founder and the company’s COO, “as well as provide commercial real estate the capability to transform and monetize under-utilized spaces with premium wellness experiences.”

In June 2019, Hydra Studios opened its first private studio in NYC at Convene’s 530 Fifth Avenue location, and later that year entered into an agreement with Silverstein Properties to open its flagship on the ground floor of 120 Wall Street, joining the real estate company’s roster of amenity concepts for its tenants and the surrounding Lower Manhattan community.

For more information on Hydra Studios please visit https://hydranewyork.com.

About Hydra Studios

Hydra Studios is a network of elevated wellness studios for the modern workforce designed and operated with COVID-19 considerations built into its DNA. Seamlessly combining the highest standards of luxury and cleanliness, the premiere self-care destination provides clients private suites which can be reserved for fitness — including Peloton, MIRROR workout system, TRX, mats and weights — meditation, or simply a quiet place to recharge. Well-appointed locker rooms feature rainfall showers, steam rooms, infrared sauna, vanity stations, and highly coveted products from brand partners including Brooklinen, Verb, Blind Barber, Malin + Goetz and Seed. The studio’s experiential retail area offers a selection of predominantly sustainable products from female-founded companies. For those who prefer to continue working out at home, a vast library of on-demand custom classes led by renowned world-class trainers are available for streaming.

Share article on social media or email:

Leafy Green Traceability Pilots Reveal the Value of Sharing Extended Product Information During a Traceback Investigation


“The pilots provided valuable insights that will inform future outbreak response and recall protocols, helping industry to work together to support the FDA’s focus on tech-enabled traceability.”

A group of six industry organizations today released a report outlining four months of leafy green traceability pilots with supply chain partners, including growers, distributors and both independent and chain retailers, offering a detailed response to the request by the U.S. Food and Drug Administration (U.S. FDA) for improved traceability in the food system. The three pilots, conducted July through October, showed that investigations into foodborne illness outbreaks could be streamlined and conducted more effectively when supply chain partners provided extended product information during tracebacks. Additionally, the use of a standard template called the Produce Traceback Template to exchange pertinent product information was found to enhance the speed of tracing procedures. All of the pilots were successful in tracing the source of the affected product.

The six organizations that led this industry activity included: FMI-The Food Industry Association; GS1 US; the International Foodservice Distributors Association (IFDA); the Institute of Food Technologists (IFT); Produce Marketing Association (PMA) and United Fresh Produce Association (United Fresh). The pilots tracked romaine lettuce through three separate supply chains, starting with actual consumer purchases made with loyalty cards or credit cards. Small teams of industry experts mimicked the U.S. FDA’s role in conducting the traceback, including determining the data to be requested and how to format the requests for such data. Supply chain members, starting with the point-of-sale or point-of-service, used the template to provide key data elements that allowed an item to be traced back to its source. The expert groups conducting the traceback analyzed the information provided by each supply chain node to determine next steps.

Although the participants stated they would adopt the template in the future, the pilots revealed opportunities to refine the template and highlighted the need for a greater focus on education. The pilot report provides guidance on a path forward for future use of the template including additional industry training and modifications to maximize effectiveness and increase ease of use.

Notably, the data that enabled each of the teams to independently and successfully identify the finished product lot purchased by the consumer is not currently captured by the template. These data included business intelligence such as sales data, stock rotation, inventory controls and delivery schedules. These were critical in bracketing the scope of the traceback.

“As outlined in the New Era of Smarter Food Safety Blueprint, pilots like these are necessary to determine what is needed for traceability to further scale, such as testing interoperability and public and private data sharing,” said Bryan Hitchcock, executive director of IFT’s Global Food Traceability Center, on behalf of the six organizations.

“The pilots provided valuable insights that will inform future outbreak response and recall protocols, helping industry to work together to support the FDA’s focus on tech-enabled traceability.”

For more information on the pilots, please visit https://ift.org/leafygreens.

###

About FMI-The Food Industry Association – As the food industry association, FMI works with and on behalf of the entire industry to advance a safer, healthier and more efficient consumer food supply chain. FMI brings together a wide range of members across the value chain — from retailers that sell to consumers, to producers that supply food and other products, as well as the wide variety of companies providing critical services — to amplify the collective work of the industry. https://www.FMI.org

About GS1 US – GS1 US®, a member of GS1 global, is a not-for-profit information standards organization that facilitates industry collaboration to help improve supply chain visibility and efficiency through the use of GS1 Standards, the most widely used supply chain standards system in the world. Nearly 300,000 businesses in 25 industries rely on GS1 US for trading partner collaboration that optimizes their supply chains, drives cost performance and revenue growth, while also enabling regulatory compliance. They achieve these benefits through solutions based on GS1 global unique numbering and identification systems, barcodes, Electronic Product Code (EPC®)-based RFID, data synchronization, and electronic information exchange. GS1 US also manages the United Nations Standard Products and Services Code® (UNSPSC®). https://www.gs1us.org

About IFDA – The International Foodservice Distributors Association (IFDA) is the premier trade organization representing the $303 billion foodservice distribution industry and the 350,000 people it employs. This industry ensures a safe and efficient supply of food and products to more than one million restaurants and foodservice outlets in the U.S. every day. For more information, visit https://www.ifdaonline.org.

About IFT – The Institute of Food Technologists (IFT) is a global organization of approximately 13,000 individual members from 95 countries committed to advancing the science of food. Since 1939, IFT has brought together the brightest minds in food science, technology and related professions from academia, government, and industry to solve the world’s greatest food challenges. Our organization works to ensure that our members have the resources they need to learn, grow, and advance the science of food as the population and the world evolve. We believe that science is essential to ensuring a global food supply that is sustainable, safe, nutritious, and accessible to all. For more information, please visit https://www.ift.org.

About PMA – Produce Marketing Association (PMA) is the leading trade association representing companies from every segment of the global produce and floral supply chain. PMA helps members grow by providing business solutions that expand business opportunities and increase sales and consumption. For more information, visit https://www.pma.com.

About United Fresh – Founded in 1904, the United Fresh Produce Association brings together companies across every segment of the fresh produce supply chain, including growers, shippers, fresh cut processors, wholesalers, distributors, retailers, foodservice operators, industry suppliers and allied associations. We empower industry leaders to shape sound government policy. We deliver the resources and expertise companies need to succeed in managing complex business and technical issues. We provide the training and development individuals need to advance their careers in produce. Through these endeavors, we unite out industry with a common purpose – to build long-term value for our members and grow produce consumption. For more information, visit https://www.unitedfresh.org.

Media Contacts:

FMI: Heather Garlich, hgarlich@fmi.org, 202-220-0616

GS1 US: Kaitlin Friedmann, kfriedmann@gs1us.org, 609-620-8074

IFDA: Meghan Cieslak, mcieslak@ifdaonline.org, 703-962-9950

IFT: Jennifer Garcia, JGarcia@ift.org, 312-604-0273

PMA: Cassidy Taylor, ctaylor@pma.com, 860-716-5586

United Fresh: Mary Coppola, mcoppola@unitedfresh.org 202-303-3425

RevSpring Announces New RevSpring Predict™ Optimization Score to Present Personalized Payment Plans


“The new payment plan optimization score…increases the likelihood that patients accept and fulfill payment plans RevSpring Predict™ proposes,” said April Wilson, vice president of analytics at RevSpring.

RevSpring, a leading provider of healthcare financial engagement and payment solutions, today announced a new payment plan optimization score. This new propensity score within RevSpring Predict™ represents another major step forward in RevSpring’s ability to leverage analytics to improve patients’ financial journeys, while helping providers collect payments and achieve revenue management goals. This new predictive score identifies both the “sweet spot” for the installment payment amount, as well as the duration of a recommended payment plan.

RevSpring Predict is an advancement in propensity to pay modeling that enhances predictability at more touchpoints throughout the patient payment journey to increase payments. The payment plan optimization score takes it a step further by allowing healthcare providers to present an even more precise payment plan all within their pre-determined guidelines.

“The new payment plan optimization score is the result of increasing sophistication in our use of patient analytics,” said April Wilson, vice president of analytics at RevSpring. “We’re excited because it increases the likelihood that patients accept and fulfill payment plans RevSpring Predict proposes. And patients using RevSpring’s PersonaPay™ portal will appreciate the flexibility it provides for adjusting their own payment terms within the provider’s business rules. Either way, patients and providers win.”

Unlike credit score-based models that are one-dimensional and therefore less precise in terms of predicting payment behavior in financially underserved segments, RevSpring Predict—including the new payment plan optimization score—achieves a higher standard of precision because it uses more human context, including behavioral characteristics, the stage of the patient in their healthcare journey, and more. Through iterative modeling and machine learning techniques, RevSpring uses science to create a more flexible and compassionate payment experience for the patient. This means providers can have confidence that they are matching the best payment option to the needs of the patient at the right time—and ultimately improve patient loyalty and satisfaction—while increasing payments.

About RevSpring

RevSpring leads the market in financial communications and payment solutions that inspire patients to pay. The company has built the industry’s most comprehensive and impactful suite of patient engagement, OmniChannel communications and payment solutions backed by behavior analysis, propensity-to-pay scoring, contextual messaging, and user experience best practices. Using proprietary data analytics to tailor the engagement from pre-service to post-service, we improve the financial experience and outcomes for providers and their patients. To learn more, visit revspringinc.com/healthcare.

Share article on social media or email:

New Asthma Guidelines Published in The Journal of Allergy and Clinical Immunology, an Official Journal of the AAAAI


AAAAI Logo

“Inclusion of implementation guidance and shared decision making will enable providers to assure optimal care for their patients with asthma.” – AAAAI President Mary Beth Fasano, MD, MSPH, FAAAAI.

For the first time since 2007, the National Asthma Education and Prevention Program (NAEPP) Coordinating Committee, coordinated by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH), has updated its asthma guidelines.

The full document, 2020 Focused Updates to the Asthma Management Guidelines: A Report from the NAEPP Coordinating Committee Expert Panel Working Group, was published in the December issue of The Journal of Allergy and Clinical Immunology (JACI), an official journal of the American Academy of Allergy, Asthma & Immunology (AAAAI).

“The publication of the 2020 Focused Updates to the Asthma Management Guidelines represents a significant advance in asthma care. Inclusion of implementation guidance and shared decision making will enable providers to assure optimal care for their patients with asthma. I would like to thank Dr. Giselle Mosnaim for her work as the AAAAI representative to the NAEPP Coordinating Committee. In addition, a special thanks to AAAAI members Drs. Robert Lemanske, Michael Schatz, Alan Baptist, Kathryn Blake, and Edward Brooks who served on the NAEPP Coordinating Committee Expert Panel Working Group,” said AAAAI President Mary Beth Fasano, MD, MSPH, FAAAAI.

The newly published asthma guidelines contain updated recommendations that cover the following six different topics:

Fractional Exhaled Nitric Oxide (FeNO) Test

The document lists four recommendations when it comes to FeNO testing. A FeNO test is a way to determine how much lung inflammation is present and how well inhaled steroids are suppressing this inflammation.

FeNO testing is not recommended for children aged 0-4 who experience recurrent wheezing to predict the future development of asthma.

For anyone 5 years and older, FeNO testing recommendations are somewhat different. It is not recommended to use FeNO as the only measurement for asthma control. It is recommended for individuals with asthma symptoms if a diagnosis is uncertain using other testing methods such as spirometry and clinical history. Additionally, for those with persistent allergic asthma, if there is uncertainty in choosing, monitoring, or adjusting asthma treatment therapies based on other methods, the Expert Panel conditionally recommends adding FeNO measurement to help monitor and manage asthma.

Allergen Mitigation

Another four recommendations were made regarding allergen mitigation as it relates to asthma. Allergen mitigation interventions are not recommended for individuals with asthma who lack sensitization to specific indoor allergens or who don’t have any indoor allergen symptoms. For those who do have confirmed allergies to indoor allergens, multicomponent allergen-specific interventions are recommended.

The Expert Panel recommends the use of pest management alone or as part of a multicomponent allergen-specific mitigation intervention for individuals with asthma who are exposed and have symptoms related to exposure to pests such as cockroaches and rodents. For those with allergies to dust mites, the new recommendations do not support impermeable pillow/mattress covers alone but only as part of a multicomponent allergen-specific intervention.

Inhaled Corticosteroids (ICS)

ICS are medications used to treat asthma and were the subject of five recommendations. Low-dose ICS is recommended for individuals 12 and older with mild persistent asthma, either daily or as needed along with short-acting beta-agonists (SABA). For those 4 years and older with mild to moderate persistent asthma who adhere to daily ICS treatment, it is recommended that healthcare workers do not increase ICS doses in the short-term due to increased symptoms.

For moderate to severe persistent asthma, it is recommended to use ICS-formoterol in a single inhaler for daily asthma control and as reliever therapy. That recommendation varies slightly depending on the age group. In patients 4 to 11 years, the single inhaler is recommended compared to using a higher-dose ICS for daily controller therapy and SABA for quick-relief. It is also recommended over same-dose ICS-long-acting beta agonists (LABA) as a daily therapy with SABA for quick relief. For those 12 and older, the single inhaler is recommended compared to a higher-dose ICS-LABA for daily therapy and SABA for quick relief.

For children aged 0-4 who have recurrent wheezing due to respiratory tract infections but no wheezing between infections, a short course of daily ICS and as-needed SABA for quick-relief is recommended compared to SABA as-needed only.

Long-acting Muscarinic Antagonist (LAMA)

The document lists three recommendations when it comes to LAMA, which is a class of medications used for COPD that sometimes may be used for asthma.

It is not recommended to add LAMA to ICS therapy, compared to adding LABA to ICS therapy in children 12 and over with persistent, uncontrolled asthma. In the same population, LAMA is recommended to be added to ICS controller therapy if LABA is not used, compared to continuing the same dose of ICS alone. Adding LAMA to ICS-LABA is recommended in this population compared to continuing the same dose of ICS-LABA for uncontrolled asthma.

Immunotherapy

Two recommendations were released regarding immunotherapy and allergic asthma. The first recommends the use of subcutaneous immunotherapy (SCIT) for individuals 5 years and up as an additional treatment to standard medications in individuals whose asthma is controlled at the initiation, build-up and maintenance phases of immunotherapy.

For those with persistent allergic asthma, the use of sublingual immunotherapy (SLIT) in asthma treatment is not recommended.

Bronchial Thermoplasty (BT)

One recommendation was released regarding BT, a non-drug outpatient procedure developed to treat severe, persistent asthma. This treatment is not recommended for individuals 18 and older with persistent asthma. For those over 18 who are less concerned about potential harms and more concerned with potential benefits, they may consider BT.

Dr. Robert Lemanske, who as previously mentioned is a member of the Expert Panel Working Group that authored the guidelines, provided some context on how they were updated. “The updates were developed using some new approaches compared to those used previously. First, it was not a complete revision but rather a focus on six topic areas that were decided upon initially by a needs assessment committee. Second, it used a new technique of evaluating clinical data called GRADE (Grading of Recommendations Assessment, Development, and Evaluation). Third, was the inclusion of an Implementation Guidance (IG) section for each recommendation. The IG section provides further clarification of the population to which the recommendation applies, exceptions, and practical aspects of how to use the recommendation in patient care. At the end of each IG section is a list of issues suggested by the Expert Panel to communicate to patients as part of shared decision making about whether to use the therapy or intervention presented in the recommendation.”

“From the beginning, the 2020 Focused Updates to the Asthma Management Guidelines was designed to help primary care providers, specialists, and patients work together to make decisions about asthma care,” said James P. Kiley, PhD, director of the Division of Lung Diseases at the NHLBI, a part of the NIH. “Our goal was to provide clear summaries about each of the new recommendations, information to share with patients, and updated treatment diagrams.”

You can learn more about asthma on the AAAAI website, aaaai.org.

The American Academy of Allergy, Asthma & Immunology (AAAAI) represents allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic and immunologic diseases. Established in 1943, the AAAAI has more than 7,100 members in the United States, Canada and 72 other countries. The AAAAI’s Find an Allergist/Immunologist service is a trusted resource to help you find a specialist close to home.